DNMT3A and acute myeloid leukemia: In Professor Qian’s talk—“Development of a novel therapeutic approach against DNMT3A-mutant acute myeloid leukemia”—he reminded the audience how DNMT3A was the most frequently mutated gene in ARCH, and was associated with increased risk of hematologic malignancies including AML.